Partner Content Partner Content Highly Potent APIs 2019 Conference: Interview with Bayer Pha... Latest Developments in HPAPI
Events Partner Content Limited Places Available for J+D Forecasting Training Zurich Limited places for J+D's Pharma Forecasting Training
Partner Content Partner Content J+D and the University of Bath School of Management Collabor... J+D recently provided forecasting training materials to the Strategy & Organisation Division of the University of Bath School of Management.
Partner Content Partner Content Shortlist for Best Pharma Partnership with NHS at HSJ Partne... HSJ Shortlist announcement
Events Partner Content The Pharma Forecasting Workshop - Fundamentals of Forecastin... J+D Interactive Pharma Forecasting Workshop
Partner Content Partner Content Antibiotic Class Emerges through Digestive Enzyme SMi Group Reports: The official agenda and highlights
News Alzheimer's biotech Korsana to go public via reverse merger By merging with Cyclerion, Korsana will get a Nasdaq listing and additional cash to develop its new-generation amyloid-targeting drug for Alzheimer's.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
